4basebio PLC 88Q.F Stock
4basebio PLC Price Chart
4basebio PLC 88Q.F Financial and Trading Overview
| 4basebio PLC stock price | 15.5 EUR |
| Previous Close | 6.65 EUR |
| Open | 5.9 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 5.9 - 6.65 EUR |
| 52 Week Range | 4.52 - 8.35 EUR |
| Volume | 123 EUR |
| Avg. Volume | 168 EUR |
| Market Cap | 82.27M EUR |
| Beta (5Y Monthly) | 1.073099 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.59 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
88Q.F Valuation Measures
| Enterprise Value | 80.67M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 306.98434 |
| Price/Book (mrq) | 11.50519 |
| Enterprise Value/Revenue | 301.008 |
| Enterprise Value/EBITDA | -15.124 |
Trading Information
4basebio PLC Stock Price History
| Beta (5Y Monthly) | 1.073099 |
| 52-Week Change | 29.41% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.35 EUR |
| 52 Week Low | 4.52 EUR |
| 50-Day Moving Average | 6.91 EUR |
| 200-Day Moving Average | 7.27 EUR |
88Q.F Share Statistics
| Avg. Volume (3 month) | 168 EUR |
| Avg. Daily Volume (10-Days) | 154 EUR |
| Shares Outstanding | 12.32M |
| Float | 5.89M |
| Short Ratio | N/A |
| % Held by Insiders | 62.18% |
| % Held by Institutions | 7.97% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2115.29% |
| Gross Margin | 89.17% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -26.85% |
| Return on Equity (ttm) | -54.74% |
Income Statement
| Revenue (ttm) | 268K EUR |
| Revenue Per Share (ttm) | 0.02 EUR |
| Quarterly Revenue Growth (yoy) | -27.00000000000000000000000000000000% |
| Gross Profit (ttm) | N/A |
| EBITDA | -5334000 EUR |
| Net Income Avi to Common (ttm) | -5150000 EUR |
| Diluted EPS (ttm) | -0.49 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.59M EUR |
| Total Cash Per Share (mrq) | 0.37 EUR |
| Total Debt (mrq) | 3.35M EUR |
| Total Debt/Equity (mrq) | 47.05 EUR |
| Current Ratio (mrq) | 3.885 |
| Book Value Per Share (mrq) | 0.578 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4704000 EUR |
| Levered Free Cash Flow (ttm) | -5446750 EUR |
Profile of 4basebio PLC
| Country | Germany |
| State | N/A |
| City | Cambridge |
| Address | 25 Norman Way |
| ZIP | CB24 5QE |
| Phone | 44 1223 967 943 |
| Website | https://www.4basebio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 61 |
4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. It provides AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. The company offers access to its targeted non-viral delivery platform, Hermes. It serves biotech, pharma, and contract development and manufacturing organization. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
Q&A For 4basebio PLC Stock
What is a current 88Q.F stock price?
4basebio PLC 88Q.F stock price today per share is 15.5 EUR.
How to purchase 4basebio PLC stock?
You can buy 88Q.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for 4basebio PLC?
The stock symbol or ticker of 4basebio PLC is 88Q.F.
Which industry does the 4basebio PLC company belong to?
The 4basebio PLC industry is Biotechnology.
How many shares does 4basebio PLC have in circulation?
The max supply of 4basebio PLC shares is 12.81M.
What is 4basebio PLC Price to Earnings Ratio (PE Ratio)?
4basebio PLC PE Ratio is now.
What was 4basebio PLC earnings per share over the trailing 12 months (TTM)?
4basebio PLC EPS is -0.59 EUR over the trailing 12 months.
Which sector does the 4basebio PLC company belong to?
The 4basebio PLC sector is Healthcare.